American Mobile Dental Corp.
American Mobile Dental Corp. AMBD Peers
See (AMBD) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBD | $0.00 | +0.00% | 85625.00 | N/A | N/A | N/A |
| FSNUY | $11.94 | -2.10% | 107.64B | 26.54 | $0.45 | N/A |
| RVLWF | $0.04 | +97.97% | 38.58B | -0.30 | -$0.13 | N/A |
| FSNUF | $37.73 | N/A | 21.25B | 20.85 | $1.81 | N/A |
| FMCQF | $52.25 | N/A | 15.33B | 21.86 | $2.39 | +2.48% |
| BDUUY | $32.33 | N/A | 12.84B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | N/A | 11.28B | 23.67 | $0.03 | +3.13% |
| BDUUF | $0.66 | N/A | 10.49B | 22.00 | $0.03 | +3.36% |
| JDHIY | $3.25 | +100.00% | 10.40B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.33B | 26.92 | $0.12 | N/A |
Stock Comparison
AMBD vs FSNUY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, FSNUY has a market cap of 107.64B. Regarding current trading prices, AMBD is priced at $0.00, while FSNUY trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas FSNUY's P/E ratio is 26.54. In terms of profitability, AMBD's ROE is N/A, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, AMBD is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RVLWF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RVLWF has a market cap of 38.58B. Regarding current trading prices, AMBD is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, AMBD's ROE is N/A, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, AMBD is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs FSNUF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, FSNUF has a market cap of 21.25B. Regarding current trading prices, AMBD is priced at $0.00, while FSNUF trades at $37.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas FSNUF's P/E ratio is 20.85. In terms of profitability, AMBD's ROE is N/A, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, AMBD is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs FMCQF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, FMCQF has a market cap of 15.33B. Regarding current trading prices, AMBD is priced at $0.00, while FMCQF trades at $52.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas FMCQF's P/E ratio is 21.86. In terms of profitability, AMBD's ROE is N/A, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, AMBD is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BDUUY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BDUUY has a market cap of 12.84B. Regarding current trading prices, AMBD is priced at $0.00, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, AMBD's ROE is N/A, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, AMBD is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BDULF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BDULF has a market cap of 11.28B. Regarding current trading prices, AMBD is priced at $0.00, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BDULF's P/E ratio is 23.67. In terms of profitability, AMBD's ROE is N/A, compared to BDULF's ROE of +0.16%. Regarding short-term risk, AMBD is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BDUUF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BDUUF has a market cap of 10.49B. Regarding current trading prices, AMBD is priced at $0.00, while BDUUF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BDUUF's P/E ratio is 22.00. In terms of profitability, AMBD's ROE is N/A, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, AMBD is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs JDHIY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, JDHIY has a market cap of 10.40B. Regarding current trading prices, AMBD is priced at $0.00, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, AMBD's ROE is N/A, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, AMBD is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs JDHIF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, JDHIF has a market cap of 10.33B. Regarding current trading prices, AMBD is priced at $0.00, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, AMBD's ROE is N/A, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, AMBD is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs IHHHF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, IHHHF has a market cap of 9.70B. Regarding current trading prices, AMBD is priced at $0.00, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, AMBD's ROE is N/A, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, AMBD is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RMSYF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RMSYF has a market cap of 5.06B. Regarding current trading prices, AMBD is priced at $0.00, while RMSYF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RMSYF's P/E ratio is 440.00. In terms of profitability, AMBD's ROE is N/A, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, AMBD is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BUGDF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BUGDF has a market cap of 5.02B. Regarding current trading prices, AMBD is priced at $0.00, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, AMBD's ROE is N/A, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, AMBD is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RMYHY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RMYHY has a market cap of 5.00B. Regarding current trading prices, AMBD is priced at $0.00, while RMYHY trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RMYHY's P/E ratio is 513.00. In terms of profitability, AMBD's ROE is N/A, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, AMBD is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ANHGY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ANHGY has a market cap of 4.05B. Regarding current trading prices, AMBD is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, AMBD's ROE is N/A, compared to ANHGY's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BUHPF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BUHPF has a market cap of 3.86B. Regarding current trading prices, AMBD is priced at $0.00, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BUHPF's P/E ratio is 18.65. In terms of profitability, AMBD's ROE is N/A, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, AMBD is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MCVEF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MCVEF has a market cap of 2.98B. Regarding current trading prices, AMBD is priced at $0.00, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, AMBD's ROE is N/A, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, AMBD is more volatile compared to MCVEF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ORPEF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ORPEF has a market cap of 2.29B. Regarding current trading prices, AMBD is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, AMBD's ROE is N/A, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, AMBD is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBD.
AMBD vs MCVEY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MCVEY has a market cap of 2.16B. Regarding current trading prices, AMBD is priced at $0.00, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, AMBD's ROE is N/A, compared to MCVEY's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to MCVEY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs TTALF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, TTALF has a market cap of 1.64B. Regarding current trading prices, AMBD is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas TTALF's P/E ratio is 19.33. In terms of profitability, AMBD's ROE is N/A, compared to TTALF's ROE of +0.15%. Regarding short-term risk, AMBD is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RYHTY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RYHTY has a market cap of 1.47B. Regarding current trading prices, AMBD is priced at $0.00, while RYHTY trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RYHTY's P/E ratio is -20.14. In terms of profitability, AMBD's ROE is N/A, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RHCGF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RHCGF has a market cap of 1.43B. Regarding current trading prices, AMBD is priced at $0.00, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RHCGF's P/E ratio is -20.14. In terms of profitability, AMBD's ROE is N/A, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, AMBD is more volatile compared to RHCGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs LTGHY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, LTGHY has a market cap of 1.20B. Regarding current trading prices, AMBD is priced at $0.00, while LTGHY trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas LTGHY's P/E ratio is 10.90. In terms of profitability, AMBD's ROE is N/A, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, AMBD is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs LTGHF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, LTGHF has a market cap of 1.18B. Regarding current trading prices, AMBD is priced at $0.00, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, AMBD's ROE is N/A, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, AMBD is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs LWSCF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, LWSCF has a market cap of 1.16B. Regarding current trading prices, AMBD is priced at $0.00, while LWSCF trades at $12.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas LWSCF's P/E ratio is 42.00. In terms of profitability, AMBD's ROE is N/A, compared to LWSCF's ROE of +0.09%. Regarding short-term risk, AMBD is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RAFLF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RAFLF has a market cap of 1.11B. Regarding current trading prices, AMBD is priced at $0.00, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, AMBD's ROE is N/A, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, AMBD is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RKAGY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RKAGY has a market cap of 1.05B. Regarding current trading prices, AMBD is priced at $0.00, while RKAGY trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RKAGY's P/E ratio is 21.22. In terms of profitability, AMBD's ROE is N/A, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, AMBD is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RHKJF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RHKJF has a market cap of 1.02B. Regarding current trading prices, AMBD is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, AMBD's ROE is N/A, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, AMBD is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NWKHY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NWKHY has a market cap of 945.10M. Regarding current trading prices, AMBD is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NWKHY's P/E ratio is 13.22. In terms of profitability, AMBD's ROE is N/A, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, AMBD is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs EXETF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, EXETF has a market cap of 857.21M. Regarding current trading prices, AMBD is priced at $0.00, while EXETF trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas EXETF's P/E ratio is 16.05. In terms of profitability, AMBD's ROE is N/A, compared to EXETF's ROE of +0.69%. Regarding short-term risk, AMBD is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs JXFGF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, JXFGF has a market cap of 755.56M. Regarding current trading prices, AMBD is priced at $0.00, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, AMBD's ROE is N/A, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, AMBD is more volatile compared to JXFGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs WHTCF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, WHTCF has a market cap of 737.37M. Regarding current trading prices, AMBD is priced at $0.00, while WHTCF trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas WHTCF's P/E ratio is 32.40. In terms of profitability, AMBD's ROE is N/A, compared to WHTCF's ROE of +0.04%. Regarding short-term risk, AMBD is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs KDGTF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, KDGTF has a market cap of 675.13M. Regarding current trading prices, AMBD is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, AMBD's ROE is N/A, compared to KDGTF's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs WFHG Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, WFHG has a market cap of 470.60M. Regarding current trading prices, AMBD is priced at $0.00, while WFHG trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas WFHG's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to WFHG's ROE of +0.22%. Regarding short-term risk, AMBD is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ORRRY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ORRRY has a market cap of 371.54M. Regarding current trading prices, AMBD is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, AMBD's ROE is N/A, compared to ORRRY's ROE of +73.42%. Regarding short-term risk, AMBD is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BTMDW Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BTMDW has a market cap of 292.88M. Regarding current trading prices, AMBD is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, AMBD's ROE is N/A, compared to BTMDW's ROE of -0.06%. Regarding short-term risk, AMBD is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MFCSF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MFCSF has a market cap of 248.50M. Regarding current trading prices, AMBD is priced at $0.00, while MFCSF trades at $10.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MFCSF's P/E ratio is 7.97. In terms of profitability, AMBD's ROE is N/A, compared to MFCSF's ROE of +0.83%. Regarding short-term risk, AMBD is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs EVGRF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, EVGRF has a market cap of 237.07M. Regarding current trading prices, AMBD is priced at $0.00, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, AMBD's ROE is N/A, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, AMBD is more volatile compared to EVGRF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MKLNF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MKLNF has a market cap of 224.32M. Regarding current trading prices, AMBD is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, AMBD's ROE is N/A, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, AMBD is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs CHHHF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, CHHHF has a market cap of 121.49M. Regarding current trading prices, AMBD is priced at $0.00, while CHHHF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas CHHHF's P/E ratio is -39.20. In terms of profitability, AMBD's ROE is N/A, compared to CHHHF's ROE of -0.06%. Regarding short-term risk, AMBD is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs VTIAF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, VTIAF has a market cap of 104.42M. Regarding current trading prices, AMBD is priced at $0.00, while VTIAF trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas VTIAF's P/E ratio is -3.59. In terms of profitability, AMBD's ROE is N/A, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, AMBD is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MCIOF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MCIOF has a market cap of 54.04M. Regarding current trading prices, AMBD is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, AMBD's ROE is N/A, compared to MCIOF's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ASSF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ASSF has a market cap of 45.35M. Regarding current trading prices, AMBD is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ASSF's P/E ratio is -33.33. In terms of profitability, AMBD's ROE is N/A, compared to ASSF's ROE of -6.63%. Regarding short-term risk, AMBD is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs KONEF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, KONEF has a market cap of 44.34M. Regarding current trading prices, AMBD is priced at $0.00, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas KONEF's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to KONEF's ROE of -6.56%. Regarding short-term risk, AMBD is more volatile compared to KONEF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs HQDA Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, HQDA has a market cap of 18.64M. Regarding current trading prices, AMBD is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas HQDA's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to HQDA's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NVLPF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NVLPF has a market cap of 16.59M. Regarding current trading prices, AMBD is priced at $0.00, while NVLPF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NVLPF's P/E ratio is 9.50. In terms of profitability, AMBD's ROE is N/A, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, AMBD is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs USNU Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, USNU has a market cap of 14.77M. Regarding current trading prices, AMBD is priced at $0.00, while USNU trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas USNU's P/E ratio is -5.31. In terms of profitability, AMBD's ROE is N/A, compared to USNU's ROE of -0.81%. Regarding short-term risk, AMBD is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs FPCG Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, FPCG has a market cap of 10.25M. Regarding current trading prices, AMBD is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, AMBD's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs XCRT Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, XCRT has a market cap of 8.56M. Regarding current trading prices, AMBD is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas XCRT's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to XCRT's ROE of +2.48%. Regarding short-term risk, AMBD is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NUMIF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NUMIF has a market cap of 8.55M. Regarding current trading prices, AMBD is priced at $0.00, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NUMIF's P/E ratio is -0.44. In terms of profitability, AMBD's ROE is N/A, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, AMBD is more volatile compared to NUMIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BICX Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BICX has a market cap of 7.89M. Regarding current trading prices, AMBD is priced at $0.00, while BICX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BICX's P/E ratio is -1.00. In terms of profitability, AMBD's ROE is N/A, compared to BICX's ROE of +0.45%. Regarding short-term risk, AMBD is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs HLYK Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, HLYK has a market cap of 7.07M. Regarding current trading prices, AMBD is priced at $0.00, while HLYK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas HLYK's P/E ratio is -1.25. In terms of profitability, AMBD's ROE is N/A, compared to HLYK's ROE of +4.66%. Regarding short-term risk, AMBD is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs GBCS Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, GBCS has a market cap of 6.13M. Regarding current trading prices, AMBD is priced at $0.00, while GBCS trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas GBCS's P/E ratio is -2.50. In terms of profitability, AMBD's ROE is N/A, compared to GBCS's ROE of +0.56%. Regarding short-term risk, AMBD is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs RHEP Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, RHEP has a market cap of 4.75M. Regarding current trading prices, AMBD is priced at $0.00, while RHEP trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas RHEP's P/E ratio is -1.29. In terms of profitability, AMBD's ROE is N/A, compared to RHEP's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs VLXC Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, VLXC has a market cap of 4.65M. Regarding current trading prices, AMBD is priced at $0.00, while VLXC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas VLXC's P/E ratio is -6.50. In terms of profitability, AMBD's ROE is N/A, compared to VLXC's ROE of +0.68%. Regarding short-term risk, AMBD is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs EPWCF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, EPWCF has a market cap of 2.54M. Regarding current trading prices, AMBD is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas EPWCF's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, AMBD and EPWCF have similar daily volatility (196.04).
AMBD vs GRST Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, GRST has a market cap of 2.32M. Regarding current trading prices, AMBD is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas GRST's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to GRST's ROE of +0.30%. Regarding short-term risk, AMBD is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs JRSS Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, JRSS has a market cap of 1.95M. Regarding current trading prices, AMBD is priced at $0.00, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas JRSS's P/E ratio is -0.38. In terms of profitability, AMBD's ROE is N/A, compared to JRSS's ROE of +2.63%. Regarding short-term risk, AMBD is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs TOKIF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, TOKIF has a market cap of 1.78M. Regarding current trading prices, AMBD is priced at $0.00, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, AMBD's ROE is N/A, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, AMBD and TOKIF have similar daily volatility (196.04).
AMBD vs SMAS Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, SMAS has a market cap of 1.46M. Regarding current trading prices, AMBD is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas SMAS's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to SMAS's ROE of N/A. Regarding short-term risk, AMBD and SMAS have similar daily volatility (196.04).
AMBD vs MDGP Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MDGP has a market cap of 1.45M. Regarding current trading prices, AMBD is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MDGP's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to MDGP's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NOVC Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NOVC has a market cap of 1.16M. Regarding current trading prices, AMBD is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NOVC's P/E ratio is -0.20. In terms of profitability, AMBD's ROE is N/A, compared to NOVC's ROE of +0.12%. Regarding short-term risk, AMBD is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs PHMB Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, PHMB has a market cap of 1.08M. Regarding current trading prices, AMBD is priced at $0.00, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas PHMB's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to PHMB's ROE of N/A. Regarding short-term risk, AMBD and PHMB have similar daily volatility (196.04).
AMBD vs GNOW Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, GNOW has a market cap of 859731.00. Regarding current trading prices, AMBD is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas GNOW's P/E ratio is -0.01. In terms of profitability, AMBD's ROE is N/A, compared to GNOW's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs DPAT Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, DPAT has a market cap of 397353.00. Regarding current trading prices, AMBD is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas DPAT's P/E ratio is -1.65. In terms of profitability, AMBD's ROE is N/A, compared to DPAT's ROE of +0.45%. Regarding short-term risk, AMBD is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs SETO Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, SETO has a market cap of 366736.00. Regarding current trading prices, AMBD is priced at $0.00, while SETO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas SETO's P/E ratio is -2.94. In terms of profitability, AMBD's ROE is N/A, compared to SETO's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ARPC Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ARPC has a market cap of 336555.00. Regarding current trading prices, AMBD is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ARPC's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to ARPC's ROE of -0.56%. Regarding short-term risk, AMBD is more volatile compared to ARPC. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NXGT Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NXGT has a market cap of 332870.00. Regarding current trading prices, AMBD is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NXGT's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to NXGT's ROE of +0.09%. Regarding short-term risk, AMBD is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs KJFI Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, KJFI has a market cap of 278854.00. Regarding current trading prices, AMBD is priced at $0.00, while KJFI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas KJFI's P/E ratio is -0.06. In terms of profitability, AMBD's ROE is N/A, compared to KJFI's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs FCHS Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, FCHS has a market cap of 263666.00. Regarding current trading prices, AMBD is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas FCHS's P/E ratio is -0.07. In terms of profitability, AMBD's ROE is N/A, compared to FCHS's ROE of +0.12%. Regarding short-term risk, AMBD is more volatile compared to FCHS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs JNHMF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, JNHMF has a market cap of 165397.00. Regarding current trading prices, AMBD is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, AMBD's ROE is N/A, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, AMBD is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs HSMD Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, HSMD has a market cap of 153388.00. Regarding current trading prices, AMBD is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas HSMD's P/E ratio is -0.05. In terms of profitability, AMBD's ROE is N/A, compared to HSMD's ROE of -0.04%. Regarding short-term risk, AMBD is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BNYN Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BNYN has a market cap of 150549.00. Regarding current trading prices, AMBD is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BNYN's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to BNYN's ROE of -14.10%. Regarding short-term risk, AMBD and BNYN have similar daily volatility (196.04).
AMBD vs TPIA Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, TPIA has a market cap of 113827.00. Regarding current trading prices, AMBD is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas TPIA's P/E ratio is -0.15. In terms of profitability, AMBD's ROE is N/A, compared to TPIA's ROE of +0.61%. Regarding short-term risk, AMBD is more volatile compared to TPIA. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs COLRF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, COLRF has a market cap of 108333.00. Regarding current trading prices, AMBD is priced at $0.00, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas COLRF's P/E ratio is -0.01. In terms of profitability, AMBD's ROE is N/A, compared to COLRF's ROE of +0.02%. Regarding short-term risk, AMBD is more volatile compared to COLRF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NMHLY Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NMHLY has a market cap of 41741.00. Regarding current trading prices, AMBD is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, AMBD's ROE is N/A, compared to NMHLY's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs GENN Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, GENN has a market cap of 32696.00. Regarding current trading prices, AMBD is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas GENN's P/E ratio is -0.02. In terms of profitability, AMBD's ROE is N/A, compared to GENN's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs DRWN Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, DRWN has a market cap of 23978.00. Regarding current trading prices, AMBD is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas DRWN's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to DRWN's ROE of -0.01%. Regarding short-term risk, AMBD is more volatile compared to DRWN. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs CLRD Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, CLRD has a market cap of 21647.00. Regarding current trading prices, AMBD is priced at $0.00, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas CLRD's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to CLRD's ROE of +0.38%. Regarding short-term risk, AMBD is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs SCAL Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, SCAL has a market cap of 17424.00. Regarding current trading prices, AMBD is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas SCAL's P/E ratio is 0.04. In terms of profitability, AMBD's ROE is N/A, compared to SCAL's ROE of +0.07%. Regarding short-term risk, AMBD is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs CHCR Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, CHCR has a market cap of 11991.00. Regarding current trading prices, AMBD is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas CHCR's P/E ratio is -0.00. In terms of profitability, AMBD's ROE is N/A, compared to CHCR's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ACGI Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ACGI has a market cap of 10477.00. Regarding current trading prices, AMBD is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ACGI's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to ACGI's ROE of +1.11%. Regarding short-term risk, AMBD is more volatile compared to ACGI. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs CEVE Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, CEVE has a market cap of 7709.00. Regarding current trading prices, AMBD is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas CEVE's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to CEVE's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NAFS Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NAFS has a market cap of 7007.00. Regarding current trading prices, AMBD is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NAFS's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to NAFS's ROE of +1.02%. Regarding short-term risk, AMBD is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs PRMD Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, PRMD has a market cap of 5610.00. Regarding current trading prices, AMBD is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas PRMD's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to PRMD's ROE of +0.73%. Regarding short-term risk, AMBD is more volatile compared to PRMD. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MSGP Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MSGP has a market cap of 5191.00. Regarding current trading prices, AMBD is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MSGP's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to MSGP's ROE of +0.27%. Regarding short-term risk, AMBD is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MSITF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MSITF has a market cap of 4800.00. Regarding current trading prices, AMBD is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MSITF's P/E ratio is -0.00. In terms of profitability, AMBD's ROE is N/A, compared to MSITF's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to MSITF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs ERUC Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, ERUC has a market cap of 3915.00. Regarding current trading prices, AMBD is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas ERUC's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to ERUC's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs SLHPF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, SLHPF has a market cap of 3901.00. Regarding current trading prices, AMBD is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas SLHPF's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, AMBD and SLHPF have similar daily volatility (196.04).
AMBD vs WEQL Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, WEQL has a market cap of 3534.00. Regarding current trading prices, AMBD is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas WEQL's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to WEQL's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BBAL Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BBAL has a market cap of 3354.00. Regarding current trading prices, AMBD is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BBAL's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to BBAL's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs PAOG Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, PAOG has a market cap of 2478.00. Regarding current trading prices, AMBD is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas PAOG's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to PAOG's ROE of +0.08%. Regarding short-term risk, AMBD is more volatile compared to PAOG. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NMMCF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NMMCF has a market cap of 2087.00. Regarding current trading prices, AMBD is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, AMBD's ROE is N/A, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs PPRG Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, PPRG has a market cap of 1580.00. Regarding current trading prices, AMBD is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas PPRG's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to PPRG's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs OHAQ Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, OHAQ has a market cap of 1375.00. Regarding current trading prices, AMBD is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, AMBD's ROE is N/A, compared to OHAQ's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs BNKL Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, BNKL has a market cap of 1248.00. Regarding current trading prices, AMBD is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas BNKL's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to BNKL's ROE of -7.69%. Regarding short-term risk, AMBD is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs MAHN Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, MAHN has a market cap of 1211.00. Regarding current trading prices, AMBD is priced at $0.00, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas MAHN's P/E ratio is 0.05. In terms of profitability, AMBD's ROE is N/A, compared to MAHN's ROE of N/A. Regarding short-term risk, AMBD and MAHN have similar daily volatility (196.04).
AMBD vs SLHGF Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, SLHGF has a market cap of 398.00. Regarding current trading prices, AMBD is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, AMBD's ROE is N/A, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, AMBD is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs LHRP Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, LHRP has a market cap of 340.00. Regarding current trading prices, AMBD is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas LHRP's P/E ratio is 0.00. In terms of profitability, AMBD's ROE is N/A, compared to LHRP's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.
AMBD vs NMSCA Comparison
AMBD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBD stands at 85625.00. In comparison, NMSCA has a market cap of 275.00. Regarding current trading prices, AMBD is priced at $0.00, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBD currently has a P/E ratio of N/A, whereas NMSCA's P/E ratio is N/A. In terms of profitability, AMBD's ROE is N/A, compared to NMSCA's ROE of N/A. Regarding short-term risk, AMBD is more volatile compared to NMSCA. This indicates potentially higher risk in terms of short-term price fluctuations for AMBD.